Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E. Antonia SJ, et al. Among authors: pillai rn. Lancet Oncol. 2016 Jul;17(7):883-895. doi: 10.1016/S1470-2045(16)30098-5. Epub 2016 Jun 4. Lancet Oncol. 2016. PMID: 27269741 Free article. Clinical Trial.
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
Sharma P, Callahan MK, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai RN, Ott PA, de Braud F, Morse M, Le DT, Jaeger D, Chan E, Harbison C, Lin CS, Tschaika M, Azrilevich A, Rosenberg JE. Sharma P, et al. Among authors: pillai rn. Lancet Oncol. 2016 Nov;17(11):1590-1598. doi: 10.1016/S1470-2045(16)30496-X. Epub 2016 Oct 9. Lancet Oncol. 2016. PMID: 27733243 Free PMC article. Clinical Trial.
Small cell lung cancer: therapies and targets.
Pillai RN, Owonikoko TK. Pillai RN, et al. Semin Oncol. 2014 Feb;41(1):133-42. doi: 10.1053/j.seminoncol.2013.12.015. Epub 2013 Dec 12. Semin Oncol. 2014. PMID: 24565587 Free PMC article. Review.
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
Pillai RN, Aisner J, Dahlberg SE, Rogers JS, DiPaola RS, Aisner S, Ramalingam SS, Schiller JH. Pillai RN, et al. Cancer Chemother Pharmacol. 2014 Jul;74(1):177-83. doi: 10.1007/s00280-014-2427-7. Epub 2014 May 24. Cancer Chemother Pharmacol. 2014. PMID: 24858462 Free PMC article. Clinical Trial.
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
Steuer CE, Behera M, Ernani V, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS. Steuer CE, et al. Among authors: pillai rn. JAMA Oncol. 2017 Aug 1;3(8):1120-1129. doi: 10.1001/jamaoncol.2016.4280. JAMA Oncol. 2017. PMID: 27978552 Review.
New Treatment Options in Advanced Squamous Cell Lung Cancer.
Paik PK, Pillai RN, Lathan CS, Velasco SA, Papadimitrakopoulou V. Paik PK, et al. Among authors: pillai rn. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e198-e206. doi: 10.1200/EDBK_237829. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099625 Free article. Review.
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Higgins KA, Pillai RN, Chen Z, Tian S, Zhang C, Patel P, Pakkala S, Shelton J, Force SD, Fernandez FG, Steuer CE, Owonikoko TK, Ramalingam SS, Bradley JD, Curran WJ. Higgins KA, et al. Among authors: pillai rn. J Thorac Oncol. 2017 Nov;12(11):1687-1695. doi: 10.1016/j.jtho.2017.07.036. Epub 2017 Sep 13. J Thorac Oncol. 2017. PMID: 28919394 Free article. Clinical Trial.
Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414).
Pillai RN, Ramalingam SS, Thayu M, Lorenzini P, Alvarez Arias DA, Moy C, Hutnick N, Knoblauch R, Feng H, Kane C, Horn L, Reck M, Ponce S; LUC2001 Investigators. Pillai RN, et al. JTO Clin Res Rep. 2020 Oct 7;2(2):100104. doi: 10.1016/j.jtocrr.2020.100104. eCollection 2021 Feb. JTO Clin Res Rep. 2020. PMID: 34589982 Free PMC article.
69 results